Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Recruiting · NCT05401357 · Registry updated 2022-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. | eye disorder, glaucoma, ocular hypertension, open-angle glaucoma | Recruiting | Phase 3 | 2022-08-10 | NCT05401357 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amneal Pharmaceuticals, LLC | 5 |
| CBCC Global Research | 6 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cheyenne Eye Clinic & Surgery Center | Cheyenne | United States | 1 |
| Clayton Eye Clinical Research, LLC | Morrow | United States | 2 |
| Coastal Research Associates, LLC | Roswell | United States | 2 |
| Eye Research Foundation Inc. | Newport Beach | United States | 1 |
| Houston Eye Associates, North Loop | Houston | United States | 1 |
| Keystone Research | Austin | United States | 2 |
| North Bay Eye Associates, Inc. | Petaluma | United States | 4 |
| Toyos Clinic | Nashville | United States | 3 |
| Volusia Eye Associates | New Smyrna Beach | United States | 1 |